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Methods: One-hundred patients undergoing arthroscopic meniscectomy were allocated randomly
to receive intra-articular 20 mL of isotonic saline containing 50 lg/kg midazolam (midazolam
group (group M),the bupivacaine group (group B) received 0.25% (20 mL) bupivacaine, and the
midazolam with bupivacaine group (group MB) received bupivacaine 0.25% and 50 lg/kg of
midazolam in 20 mL. The postoperative analgesia was assessed using visual analog score at rest
and during movement at 1/2 h, 1 h, 2 h, 6 h, 12 h, and 24 h.
Results: Patients in group MB showed signiﬁcantly lower visual analog scores, both at rest and
during movement, long time to ﬁrst postoperative analgesic request, as well as reduced total anal-
gesic consumption than the other two groups.rtment of Anesthesiology and
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Arthroscopic knee procedures are commonly performed for
outpatients setting using different anesthetic techniques includ-
ing general, spinal, epidural, regional nerve block and local
anesthesia, one of the important regime is the intra-articular
injection of various drugs such as opioid, non-steroidal anti-
inﬂammatory, clonidine, neostigmine, local anesthetics and
ketamine [1–4].
The use of intra-articular bupivacaine for knee arthroscopy
has been gained worldwide popularity either alone or in com-
bination with other intra-articular additives [5,6].
Midazolam, a benzodiazepine (BDP) agonist has a well set-
tled peripheral analgesic effect, via the peripheral benzodiaze-
pine receptors which distributed in various organs and joints,
these receptors are present in the outer mitochondrial mem-
brane and bind with a different afﬁnities to various benzodi-
azepines [7].
The present study was performed to investigate the effects
of intra-articular injection of midazolam with or without
bupivacaine on the postoperative visual analog pain scores
(VASs) and postoperative analgesic consumption after knee
arthroscopic surgery.
2. Patients and methods
After obtaining local ethics committee approval and an
informed written consent, one-hundred patients with ASA I
and II undergoing arthroscopic meniscectomy were enrolled
in this randomized, prospective, blinded study.
Patients with cardiac, hepatic or renal disorder, patients less
than 18 years old, patients with communications barriers for the
interpretation of VAS, patients with drug allergy, and preoper-
ative use of oral narcotics, non-steroidal anti-inﬂammatory, and
opioid were excluded from the study.
Patients were randomly assigned into three groups (25
patients for each), using a computer generated randomization
code included in sequentially numbered, sealed, opaque enve-
lopes. Patients in group M received (intra-articular injection
of midazolam 50 lg/kg in 20 mL isotonic saline). Patients in
group B received (intra-articular injection of 20 mL bupiva-
caine 0.25%). Patients in group MB received (intra-articular
injection of midazolam 50 lg/kg and bupivacaine 0.25% in
20 mL isotonic saline) at the end of surgery.
The study solutions look identical and were prepared before
surgery by a blind investigator to the study protocol and the
patient’s randomization code.
The primary objective included the postoperative VAS pain
scores, Secondary outcome variables included the time of the
ﬁrst analgesic request and the total doses of ﬁrst 24 h postop-
erative ketorolac consumption.
The studied populations were instructed about the postop-
erative assessment of pain severity using a 10 cm visual analog
scale (VAS) with 0, no pain, with 10, the worst pain.Standard intraoperative monitoring included 3-lead ECG,
pulse oximeter, capnography and non-invasive arterial blood
pressure were applied. Baseline heart rate (HR) and mean arte-
rial blood pressure (MAP), were recorded.
Anesthetic management was standardized in all studied
population, no premedications were given and surgery was
done under general anesthesia, after preoxygenation, anesthe-
sia was induced by using IV fentanyl 2 lg/kg, propfol 2 mg/kg
and tracheal intubation was facilitated by atracurium 0.5 mg/
kg, the lungs were mechanically ventilated to maintain normo-
capnia. Anesthesia was maintained using isoﬂurane 1 MAC in
100% of oxygen and atracurium increments of 0.1–0.2 mg/kg.
A pneumatic tourniquet was applied to the operative side
and inﬂated to 300 mmHg to provide surgical homeostasis.
At the end of surgery, a blind surgeon to the study protocol
injected the prepared study solution intra-articularly into the
knee joint using the arthroscopic guidance 10 min before the
tourniquet release. No postoperative intra-articular drainage
was used for any patients.
At the completion of surgery, isoﬂurane was discontinued
and the residual neuromuscular blockade was reversed using
neostigmine 50 lg/kg and atropine 20 lg/kg and the patients
were extubated. Patients were admitted to the recovery room.
Postoperative monitoring of patients included heart rate
(HR), mean arterial blood pressure (MAP) and oxygen
saturation.
Postoperative analgesia was assessed by using VAS at 0.5,
1, 2, 6, 12, 24 h, evaluation was done both at rest and during
movement (active movement of the knee joint), all data were
collected by a blinded observer who was unaware of the
patients’ assignment group.
Postoperative analgesia was achieved using IV ketorolac
(30 mg) per dose every 8 h if required with a maximum daily
dose of 120 mg. Tramadol 50 mg i.v was used as a rescue anal-
gesic if the patients continued to suffer pain after ketorolac
administration .
The time from completion of surgery until the ﬁrst analge-
sic dose requirements and the total analgesic dose during the
ﬁrst 24 h after the operation were also recorded.
Side effects from intra-articular injection of midazolam and
bupivacaine such as signiﬁcant reduction in arterial blood pres-
sure or heart rate (more than 15% from baseline), arrhythmia,
ﬂushing, nausea, vomiting, or respiratory depression, were
recorded during the ﬁrst 24 h period after surgery.
3. Statistical analysis
The statistical analysis of data done by using SPSS (SPSS, Inc.,
Chicago, IL) version 16. Kolmogorov–Smirnov test was done
to test the normality of data distribution .The description of
the data done in form of mean (+/) SD for quantitative data,
and Frequency & proportion for Qualitative data. Repeated
measure analysis of variance was done. One way ANOVA
and Tukey-Honest post hoc tests were used to compare the
Graph 1 Visual analog score at rest preoperative and postop-
erative gpM – midazolam group gpB – bupivacaine group gpMB –
midazolam + bupivacaine signiﬁcant reduction of VAS in gpMB
in comparison to gpM and gpB.
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was used for categorical data.
P value less than 0.05 was considered signiﬁcant.
We calculated the needed sample size from our preliminary
data. We found that 22 patients were needed in each group.
The total number of studied patients in each group would be
25 patients after the adding of 10% to compensate for the
dropped cases during the study.
4. Result
All patients completed the study protocol, as regard the patients
age, gender, body weight and height, are shown in (Table 1),
with no statistical signiﬁcant difference among the studied
groups.
Tourniquet time and duration of surgery were similar
among the studied groups (Table 2).
There were no statistical signiﬁcant difference between
groups as regard the perioperative hemodynamic changes, O2
saturation, and end-tidal CO2.
Postoperative pain scores at rest were signiﬁcantly lower in
group MB in comparison to group M at 0.5, 1, 2, 6, and 12 h
after surgery (p-value 60.003) (Graph 1).
Postoperative pain scores in the patients in group MB were
signiﬁcantly lower at rest than those in group B at 2 h and 6 h
(p-value 60.03) (Graph 1).
Pain scores in the patients in group MB were signiﬁcantly
lower during movement than in group M and group B at 0.5,
1, 2, 6, 12, and 24 h after surgery (p-value 60.02) (Graph 2).
There were no statistical signiﬁcant difference as regarding
postoperative pain scores at movement in groups B and group
M, although postoperative pain scores at rest were lower inTable 1 demographic data.
Variable GpM GpB GpMB
Age (year) 43.68 ± 8.68 43.68 ± 8.68 44.12 ± 8.44
Male 12(48.0%) 11(44.0%) 13(52.0%)
Female 13(52.2%) 14(56.0%) 12(48.0%)
Body weight (kg) 79.40 ± 7.11 77.96 ± 7.82 78.08 ± 5.63
Height (cm) 165.04 ± 1.01 165.84 ± 1.81 165.60 ± 1.35
GpM – midazolam group.
GpB – bupivacaine group.
GpMB – midazolam + bupivacaine.
No statistical signiﬁcant difference among groups.
Table 2 Tourniquet time, duration of operation, total analgesic do
Variable GpM
Tourniquet time (min) 49.88 ± 2.48
Duration of operation (min) 66.44 ± 1.70
Total analgesic dose (mg) 40.71 ± 14.91
First analgesic request (min) 342.85 ± 265.66
GpM – midazolam group.
GpB – bupivacaine group.
GpMB – midazolam + bupivacaine.
P< 0.05 signiﬁcant compared GPM and GpB*.
GpM and GpB* had a signiﬁcantly shorter time to ﬁrst analgesic requesgroup B than in group M at 1, 6 and 12 h after surgery (p-
value 6 0.01) (Graphs 1 and 2).
Postoperative heart rate (HR), mean arterial blood pressure
(MAP) and oxygen saturation showed no signiﬁcant difference
between groups.
Total analgesic consumption during ﬁrst 24 h postoperative
were signiﬁcantly lower in group MB than in groups M and
group B (Table 2).
The time to ﬁrst request for analgesic after surgery was sig-
niﬁcantly longer in the patients in group MB than those in
groups M and group B (Table 2).
There were no noted side effects (such as nausea and vom-
iting, bradycardia and hypotension) among the studied pa-
tients in the three groups during the 24 h after surgery.
5. Discussion
Arthroscopic surgery is associated with variable amount of
post operative pain which caused by an irritation of free nervese, ﬁrst analgesic request.
GpB GpMB
49.84 ± 2.19 50.40 ± 2.27
66.72 ± 2.09 64.76 ± 2.22
39.00 ± 20.24* 21.42 ± 8.01
361.00 ± 295* 682.85 ± 169.48
t than GpMB.
Graph 2 Visual analog score during movement preoperative and
postoperative gpM – midazolam group gpB – bupivacaine group
gpMB – midazolam + bupivacaine signiﬁcant reduction of VAS
in gpMB in comparison to gpM and gpB.
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sule result from surgical excision and resection [8].
The main ﬁndings in this study were that the addition of
midazolam to bupivacaine achieved more effective analgesia.
Patients received intra-articular midazolame and bupivacaine
had lower postoperative pain scores, a longer analgesic dura-
tion, and lower 24-h analgesic consumption compared with
those received intraarticular either bupivacaine, or midazolam
individually.
In this study, the use of intra-articular midazolame alone
achieved comparable post operative analgesia with intra-artic-
ular bupivacaine.
The action of midazolam on peripheral receptors has been
substantiated by its efﬁcacy in enhancing the duration of anal-
gesia when used in conjunction with bupivacaine for brachial
plexus block [9]. A similar action of midazolam on GABA-A
receptors in afferent nerve endings in the knee joint may be
responsible for its analgesic action [7], Various authors have
demonstrated the presence of the GABA-A receptors in
peripheral nerves, which may have served as the mechanism
of action for IA midazolam [10].
Batra and colleagues [11], studied different doses of intra-
articular midazolam (50 lg/kg, 75 lg/kg),and they concluded
in similar to our study that The addition of intra-articular
midazolam signiﬁcantly reduced visual analog pain scores in
the early postoperative period compared with saline, they sug-
gested that midazolame may act at a peripheral site in the
joint, which was conﬁrmed in the present study, They reported
mild nausea in three patients after the use of 75 lg/kg of intra-
articular midazolam, and in two patients each after the use of
50 lg/kg midazolam or placebo, this may be due to artial vas-
cular uptake and subsequent transport to the central nervous
system. The side effects are short-lived due to the high lipophil-
icity, rapid clearance (6–11 mL/kg/min), and short half-life(1.7–2.6 h) of midazolam [9,12], so, we selected in our study
to use intra-articular midazolam in a dose of 50 lg/kg rather
than 75 lg/kg.
He et al. [13] studied of the analgesic effects of intra-artic-
ular midazolam after knee arthroscopy they found that intra-
articular midazolam signiﬁcantly reduced visual analog pain
scores in the early postoperative period (4 h) compared with
saline [(2.0 ± 0.3) vs (4.8 ± 0.4), P< 0.05], while did not in-
crease adverse effects, they concluded that intra-articular
midazolam might be an ideal choice for postoperative analge-
sia after knee arthroscopy.
In the present study there were no noted complications with
the use of intra-articular injection of midazolam which may be
due to injection in a relatively avascular area.
Elsharnouby and coworkers [14] reported that intra-articu-
lar bupivacaine after arthroscopic surgery has been safely used
with signiﬁcant decrease postoperative pain scores, reduction
of the postoperative analgesic consumption and increase the
time to take ﬁrst analgesic dose which was conﬁrmed in the
present study.
The analgesic effect of intra-articular bupivacaine after
arthroscopic surgery has been demonstrated by different stud-
ies, it was safely used after arthroscopic knee surgery with sig-
niﬁcant reduction in postoperative analgesic consumption as
well as increasing the time to ﬁrst analgesic dose demanded
[5,15,16].
In conclusion, Intra-articular administration of both
midazolam and bupivacaine improves the quality of postoper-
ative analgesia after arthroscopic meniscectomy.
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